Zanamivir (Romanian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Zanamivir" in Romanian language version.

refsWebsite

Global rank Romanian rank

16nih.gov

4^th place

14doi.org

2^nd place

3^rd place

5fda.gov

447^th place

173^rd place

3web.archive.org

1^st place

2ebi.ac.uk

5,849^th place

138^th place

2cdc.gov

218^th place

97^th place

2csiro.au

4,114^th place

2,747^th place

1cas.org

8,332^nd place

310^th place

1chemspider.com

8,573^rd place

247^th place

1drugbank.com

low place

160^th place

1harvard.edu

18^th place

27^th place

1bond.edu.au

low place

1semanticscholar.org

11^th place

638^th place

1reuters.com

49^th place

124^th place

bond.edu.au

pure.bond.edu.au

Jefferson, T; Jones, MA; Doshi, P; Del Mar, CB; Hama, R; Thompson, MJ; Spencer, EA; Onakpoya, I; Mahtani, KR (10 aprilie 2014). „Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children” (PDF). The Cochrane Database of Systematic Reviews. 4 (4): CD008965. doi:10.1002/14651858.CD008965.pub4. PMC 6464969 . PMID 24718923.

cas.org

commonchemistry.cas.org

CAS Common Chemistry, accesat în 8 aprilie 2021

cdc.gov

„2008-2009 Influenza Season Week 32 ending August 15, 2009”. Flu Activity & Surveillance. Centers for Disease Control and Prevention (CDC). 21 august 2009.
„Influenza Antiviral Medications: Summary for Clinicians”. CDC. 11 mai 2018. Accesat în 21 aprilie 2014.

chemspider.com

Zanamivir (în engleză), ChemSpider, accesat în 20 noiembrie 2016

csiro.au

csiropedia.csiro.au

„Archived copy”. Arhivat din original la 4 octombrie 2013. Accesat în 2 octombrie 2013.
„Archived copy”. Arhivat din original la 5 octombrie 2013. Accesat în 2 octombrie 2013.

doi.org

Michiels, B.; Van Puyenbroeck, K.; Verhoeven, V.; Vermeire, E.; Coenen, S. (2013). „The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviews”. PLOS One. 8 (4): e60348. Bibcode:2013PLoSO...860348M. doi:10.1371/journal.pone.0060348. PMC 3614893 . PMID 23565231.
Hu, Y.; Lu, S.; Song, Z.; Wang, W.; Hao, P.; Li, J.; Zhang, X.; Yen, H. L.; Shi, B. (2013). „Association between adverse clinical outcome in human disease caused by novel influenza a H7N9 virus and sustained viral shedding and emergence of antiviral resistance”. The Lancet. 381 (9885): 2273–2279. doi:10.1016/S0140-6736(13)61125-3. PMID 23726392.
Jefferson, T; Jones, MA; Doshi, P; Del Mar, CB; Hama, R; Thompson, MJ; Spencer, EA; Onakpoya, I; Mahtani, KR (10 aprilie 2014). „Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children” (PDF). The Cochrane Database of Systematic Reviews. 4 (4): CD008965. doi:10.1002/14651858.CD008965.pub4. PMC 6464969 . PMID 24718923.
Heneghan, CJ; Onakpoya, I; Thompson, M; Spencer, EA; Jones, M; Jefferson, T (9 d.Hr.). „Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments”. BMJ (Clinical Research Ed.). 348: g2547. doi:10.1136/bmj.g2547. PMC 3981976 . PMID 24811412.
Heneghan, C. J.; Onakpoya, I.; Thompson, M.; Spencer, E. A.; Jones, M.; Jefferson, T. (9 aprilie 2014). „Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments”. BMJ. 348 (apr09 2): g2547. doi:10.1136/bmj.g2547. PMC 3981976 . PMID 24811412.
Wang, K; Shun-Shin, M; Gill, P; Perera, R; Harnden, A (18 d.Hr.). „Neuraminidase inhibitors for preventing and treating influenza in children (published trials only)”. Cochrane Database of Systematic Reviews. 4 (4): CD002744. doi:10.1002/14651858.CD002744.pub4. PMC 6599832 . PMID 22513907.
Thorlund, Kristian; Awad, Tahany; Boivin, Guy; Thabane, Lehana (2011). „Systematic review of influenza resistance to the neuraminidase inhibitors”. BMC Infectious Diseases. 11 (1): 134. doi:10.1186/1471-2334-11-134. PMC 3123567 . PMID 21592407.
Hayden FG (decembrie 2001). „Perspectives on antiviral use during pandemic influenza”. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 356 (1416): 1877–84. doi:10.1098/rstb.2001.1007. PMC 1088564 . PMID 11779387.
Freund, B; Gravenstein, S; Elliott, M; Miller, I (1999). „Zanamivir: a review of clinical safety”. Drug Safety. 21 (4): 267–81. doi:10.2165/00002018-199921040-00003. PMID 10514019.
Cyranoski D (septembrie 2005). „Threat of pandemic brings flu drug back to life”. Nature Medicine. 11 (9): 909. doi:10.1038/nm0905-909. PMID 16145557.
Moscona A (septembrie 2005). „Neuraminidase inhibitors for influenza”. The New England Journal of Medicine. 353 (13): 1363–73. doi:10.1056/NEJMra050740. PMID 16192481.
Varghese, J. N.; Laver, W. G.; Colman, P. M. (1983). „Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 a resolution”. Nature. 303 (5912): 35–40. doi:10.1038/303035a0. PMID 6843658.
„Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid”. Virology. 58 (2): 457–63. aprilie 1974. doi:10.1016/0042-6822(74)90080-4. PMID 4362431.
„Extrapolating from sequence--the 2009 H1N1 'swine' influenza virus”. Nature Biotechnology. 27 (6): 510–3. iunie 2009. doi:10.1038/nbt0609-510. PMID 19513050.

drugbank.com

Zanamivir (în engleză), DrugBank, 17 noiembrie 2015

ebi.ac.uk

Zanamivir (în engleză), ChEMBL, accesat în 19 ianuarie 2016
ZANAMIVIR (în engleză), ChEMBL, accesat în 20 noiembrie 2016

fda.gov

zanamivir (în engleză), Global Substance Registration System, accesat în 20 noiembrie 2016
„FDA Approves a Second Drug for the Prevention of Influenza A and B in Adults and Children FDA press release March 29, 2006”. FDA.
„FDA Approves a Second Drug for the Prevention of Influenza A and B in Adults and Children”. FDA press release.
„Safe and Appropriate Use of Influenza Drugs”. Public Health Advisories (Drugs). U.S. Food and Drug Administration (FDA). 30 aprilie 2009. Arhivat din original la 4 noiembrie 2009. Accesat în 11 noiembrie 2009.
https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm186081.htm

harvard.edu

adsabs.harvard.edu

Michiels, B.; Van Puyenbroeck, K.; Verhoeven, V.; Vermeire, E.; Coenen, S. (2013). „The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviews”. PLOS One. 8 (4): e60348. Bibcode:2013PLoSO...860348M. doi:10.1371/journal.pone.0060348. PMC 3614893 . PMID 23565231.

nih.gov

ncbi.nlm.nih.gov

Michiels, B.; Van Puyenbroeck, K.; Verhoeven, V.; Vermeire, E.; Coenen, S. (2013). „The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviews”. PLOS One. 8 (4): e60348. Bibcode:2013PLoSO...860348M. doi:10.1371/journal.pone.0060348. PMC 3614893 . PMID 23565231.
Hu, Y.; Lu, S.; Song, Z.; Wang, W.; Hao, P.; Li, J.; Zhang, X.; Yen, H. L.; Shi, B. (2013). „Association between adverse clinical outcome in human disease caused by novel influenza a H7N9 virus and sustained viral shedding and emergence of antiviral resistance”. The Lancet. 381 (9885): 2273–2279. doi:10.1016/S0140-6736(13)61125-3. PMID 23726392.
Jefferson, T; Jones, MA; Doshi, P; Del Mar, CB; Hama, R; Thompson, MJ; Spencer, EA; Onakpoya, I; Mahtani, KR (10 aprilie 2014). „Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children” (PDF). The Cochrane Database of Systematic Reviews. 4 (4): CD008965. doi:10.1002/14651858.CD008965.pub4. PMC 6464969 . PMID 24718923.
Heneghan, CJ; Onakpoya, I; Thompson, M; Spencer, EA; Jones, M; Jefferson, T (9 d.Hr.). „Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments”. BMJ (Clinical Research Ed.). 348: g2547. doi:10.1136/bmj.g2547. PMC 3981976 . PMID 24811412.
Heneghan, C. J.; Onakpoya, I.; Thompson, M.; Spencer, E. A.; Jones, M.; Jefferson, T. (9 aprilie 2014). „Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments”. BMJ. 348 (apr09 2): g2547. doi:10.1136/bmj.g2547. PMC 3981976 . PMID 24811412.
Wang, K; Shun-Shin, M; Gill, P; Perera, R; Harnden, A (18 d.Hr.). „Neuraminidase inhibitors for preventing and treating influenza in children (published trials only)”. Cochrane Database of Systematic Reviews. 4 (4): CD002744. doi:10.1002/14651858.CD002744.pub4. PMC 6599832 . PMID 22513907.
Thorlund, Kristian; Awad, Tahany; Boivin, Guy; Thabane, Lehana (2011). „Systematic review of influenza resistance to the neuraminidase inhibitors”. BMC Infectious Diseases. 11 (1): 134. doi:10.1186/1471-2334-11-134. PMC 3123567 . PMID 21592407.
Hayden FG (decembrie 2001). „Perspectives on antiviral use during pandemic influenza”. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 356 (1416): 1877–84. doi:10.1098/rstb.2001.1007. PMC 1088564 . PMID 11779387.
Freund, B; Gravenstein, S; Elliott, M; Miller, I (1999). „Zanamivir: a review of clinical safety”. Drug Safety. 21 (4): 267–81. doi:10.2165/00002018-199921040-00003. PMID 10514019.
Cyranoski D (septembrie 2005). „Threat of pandemic brings flu drug back to life”. Nature Medicine. 11 (9): 909. doi:10.1038/nm0905-909. PMID 16145557.
Moscona A (septembrie 2005). „Neuraminidase inhibitors for influenza”. The New England Journal of Medicine. 353 (13): 1363–73. doi:10.1056/NEJMra050740. PMID 16192481.
Varghese, J. N.; Laver, W. G.; Colman, P. M. (1983). „Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 a resolution”. Nature. 303 (5912): 35–40. doi:10.1038/303035a0. PMID 6843658.
„Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid”. Virology. 58 (2): 457–63. aprilie 1974. doi:10.1016/0042-6822(74)90080-4. PMID 4362431.
„Extrapolating from sequence--the 2009 H1N1 'swine' influenza virus”. Nature Biotechnology. 27 (6): 510–3. iunie 2009. doi:10.1038/nbt0609-510. PMID 19513050.

pubchem.ncbi.nlm.nih.gov

„Zanamivir”, zanamivir (în engleză), PubChem, accesat în 20 noiembrie 2016
„Zanamivir”, zanamivir (în engleză), PubChem, accesat în 19 octombrie 2016

reuters.com

Hirschler, Ben (19 ianuarie 2011). „GSK tests intravenous flu drug vs Roche's Tamiflu”. Reuters.

semanticscholar.org

Moscona A (septembrie 2005). „Neuraminidase inhibitors for influenza”. The New England Journal of Medicine. 353 (13): 1363–73. doi:10.1056/NEJMra050740. PMID 16192481.

web.archive.org

„Safe and Appropriate Use of Influenza Drugs”. Public Health Advisories (Drugs). U.S. Food and Drug Administration (FDA). 30 aprilie 2009. Arhivat din original la 4 noiembrie 2009. Accesat în 11 noiembrie 2009.
„Archived copy”. Arhivat din original la 4 octombrie 2013. Accesat în 2 octombrie 2013.
„Archived copy”. Arhivat din original la 5 octombrie 2013. Accesat în 2 octombrie 2013.